Cargando…
Malignant ascites: a source of therapeutic protein against ovarian cancer?
Ovarian cancer is the fifth leading cause of cancer-related death in the world. Some ovarian cancer patients present large amount of ascites at the time of diagnosis which may play an active role in tumor development. In earlier studies, we demonstrated that the acellular fraction of ascites can ind...
Autores principales: | Ribaux, Pascale, Britan, Aurore, Thumann, Gabriele, Delie, Florence, Petignat, Patrick, Cohen, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800269/ https://www.ncbi.nlm.nih.gov/pubmed/31666922 http://dx.doi.org/10.18632/oncotarget.27185 |
Ejemplares similares
-
NANO-SBT-PEDF delivery system: A promising approach against ovarian cancer?
por: Ribaux, Pascale, et al.
Publicado: (2023) -
Role of PAR-4 in ovarian cancer
por: Meynier, Sonia, et al.
Publicado: (2015) -
Circulating GRP78 antibodies from ovarian cancer patients: a promising tool for cancer cell targeting drug delivery system?
por: Van Hoesen, Kylie, et al.
Publicado: (2017) -
Acellular fraction of ovarian cancer ascites induce apoptosis by activating JNK and inducing BRCA1, Fas and FasL expression in ovarian cancer cells
por: Cohen, Marie, et al.
Publicado: (2014) -
GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach
por: Delie, Florence, et al.
Publicado: (2012)